FDA Inspection 1194258 — Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.

Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. — FEI 3002809097

The FDA completed an inspection of Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. on December 16, 2022 in Vienna. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 16, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Vienna (Austria)